Current Market Information

Last Trade Price (LTP) 16.20 Last Trade Date 27 March, 2025 Change -2.99 % Open Price 16.70 Day's Range 16.20 - 16.20     Total Trade 1 Total Volume 400 Close Price 16.20 Yesterday Close Price 16.70 Market Capital in BDT (mn) 1508.750

Contact Information

Designation Name Mobile Number Email Chairman Asif Iqbal Chowdhury MD Faria Binta Alam Company Secretary Md. Delwar Hossen 01766-531323 dhossen2009@gmail.com Office Address Rupayan Karim Tower, Level # 10 Road, 80-Kakrail, VIP Road, Ramna, Dhaka-1000 Phone : 02-9185352 Fax : 02-9185351 Email : adventpharma@gmail.com, ikramulca@gmail.com Website : http://www.adventpharmabd.com Factory Address Plot # B 50-54 BSCIC Industrial Estate, Kalampur, Dhamrai, Dhaka-1351.

Basic Information

Authorized Capital in BDT* (mn) 1,000.00 Paid-up Capital in BDT* (mn) 931.33 Face Value 10 Paid up Share 93132732     Market Lot 1 Sector PHARMA & CHEMICALS Market Category Z

Other Information

Listing Year 2018 Debut Trade Date 12 April, 2018 Type of Instrument     52 Week's Range 14.50 - 31.40 Year End 30 June Reserve / Surplus(mn) 538.68 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 28-Feb, 2025 30.02 0 13.01 0 56.97 As on 31-Jan, 2025 30.02 0 12.94 0 57.04 As on 31-Dec, 2024 30.02 0 12.84 0 57.14 As on 30-Jun, 2024 (year ended) 30.02 0 13.26 0 56.72     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Feb 26, 2024 A- ST-3 Stable Jan 25, 2025 Alpha Credit Rating Limited Jan 26, 2023 BBB+ ST-3 Stable Jan 25, 2024 Alpha Credit Rating Limited Jan 26, 2022 BBB+ ST-3 Stable Jan 25, 2023 Alpha Credit Rating Limited         Half Year End (HY) Information  202412 HY Net Turnover(mn)  222.96 HY Net Profit after tax(mn)  31.82 HY EPS  0.34  AGM Information   AGM Date  29 December, 2024 Record Date  20 November, 2024 Dividend(%)  1.00 (Cash only for general shareholders excluding Sponsors and Directors-June 2024) Bonus Issue  2% 2021, 10% 2019,10% 2018

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2024	0.9	0	0	0	15.78	0	83.99	0	1%C	0.39
2023	1.06	0	0	0	15.02	0	98.64	0	2%C	0.76
2022	1.05	0	0	0	14.1	0	97.53	0	2%C	0.8
2021	1.24	0	0	0	13.52	0	113.59	0	2%C,2%B	0.8
2020	1.41	0	0	0	13.5	0	117.05	0	10%B	0

Financial Statements
Quarterly Financial Statement	https://www.adventpharmabd.com/quarterly-reports/
Price Sensitive Information	https://www.adventpharmabd.com/price-sensitive-information/

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To